
Chemistry
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
M. Moret, I. P. Angona, et al.
Dive into cutting-edge drug design with our exploration of hybrid chemical language models, spearheaded by Michael Moret and team. Discover how we crafted a virtual library of novel PI3Kγ ligands, leading to the identification of potent compounds that inhibit cancer cell pathways.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.